Metastatic castration-resistant prostate cancer

This Mirrors of Medicine model is designed to get insight into the available evidence on treatment of metastatic castration-resistant prostate cancer, and to learn applying the evidence to decisions in clinical practice. Starting from a specific patient profile, you can see the considerations from an international expert panel, together with an overview of the available evidence and information from international guidelines. 

Disclaimer

The model provided here is intended exclusively for information and educational purposes, and should never replace clinical judgment. Mirrors of Medicine and their contributors cannot, in any way, be held responsible for final treatment decisions.

Target audience

Healthcare professionals involved in the management of patients with metastatic castration-resistant prostate cancer (a.o. urologists, radiation oncologists, medical oncologists, and prostate cancer nurses)

Chair

University Hospital Saint-Luc, Urology
Brussels
Belgium

Model

Panel

Moscow State Medical Stomatological University, Urology
Moscow
Russia
Bristol Haematology & Oncology Centre, Radiotherapy
Bristol
United Kingdom
Kantonsspital St. Gallen, Medical Oncology
St. Gallen
Switzerland
Kantonsspital St. Gallen, Medical Oncology
St. Gallen
Switzerland
University Hospital Saint-Luc, Urology
Brussels
Belgium
Gustave Roussy Institute, Medical Oncology
Villejuif
France
University Hospital Leuven, Radiotherapy
Leuven
Belgium
University Medical Centre Radboud, Urology
Nijmegen
Netherlands
VUmc Cancer Centre Amsterdam, Urology
Amsterdam
Netherlands